Complement Inhibition for Geographic Atrophy: A Tempting Target with Mixed Results

Complement Inhibition for Geographic Atrophy: A Tempting Target with Mixed Results

Age-related macular degeneration (AMD) is a leading cause of blindness in older adults. One of the strongest genetic risk factors for AMD is a complement factor H (CFH) gene polymorphism characterized by a tyrosine-histidine change at amino acid position 402 (Y402H). The magnitude of this associatio...

Full description

Bibliographic Details
Main Authors:	Jonathan B. Lin, Omar A. Halawa, Joan W. Miller, Demetrios G. Vavvas
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Series:	Journal of Clinical Medicine
Subjects:	age-related macular degeneration geographic atrophy complement retina drusen
Online Access:	https://www.mdpi.com/2077-0383/10/13/2890

Similar Items

Systemic Complement Activation Profiles in Nonexudative Age-Related Macular Degeneration: A Meta-Analysis
by: Jonathan B. Lin, et al.
Published: (2022-04-01)

Role of Complement in the Onset of Age-Related Macular Degeneration
by: Niloofar Piri, et al.
Published: (2023-05-01)

Geographic atrophy: pathophysiology and current therapeutic strategies
by: Kalpana Rajanala, et al.
Published: (2023-12-01)

Systemic Complement Activation Profiles in Nonexudative Age-Related Macular Degeneration
by: Jonathan B. Lin, MD, PhD, et al.
Published: (2022-06-01)

A Review of Completed and Ongoing Complement Inhibitor Trials for Geographic Atrophy Secondary to Age-Related Macular Degeneration
by: Omar A. Halawa, et al.
Published: (2021-06-01)

C1q and the classical complement cascade in geographic atrophy secondary to age-related macular degeneration
by: Ted Yednock, et al.
Published: (2022-11-01)

Complete Resolution of Central Soft Drusen without Geographic Atrophy or Choroidal Neovascularization
by: Rebecca Zeng, et al.
Published: (2022-03-01)

A Phase I, Single Ascending Dose Study of GEM103 (Recombinant Human Complement Factor H) in Patients with Geographic Atrophy
by: Arshad M. Khanani, MD, MA, et al.
Published: (2022-06-01)

Progression of Geographic Atrophy
by: Ehsan Rahimy, MD, et al.
Published: (2023-12-01)

Complement Inhibitors for Advanced Dry Age-Related Macular Degeneration (Geographic Atrophy): Some Light at the End of the Tunnel?
by: Miguel Cruz-Pimentel, et al.
Published: (2023-08-01)

Shedding Light on Photobiomodulation Therapy for Age-Related Macular Degeneration: A Narrative Review
by: Federico Fantaguzzi, et al.
Published: (2023-09-01)

Epidemiological profile of age-related macular degeneration patients in Federal University of Parana, Brazil
by: Fernando Morandini Pradella, et al.

Multimodal Imaging and En Face OCT Detection of Calcified Drusen in Eyes with Age-Related Macular Degeneration
by: Jeremy Liu, BS, et al.
Published: (2022-06-01)

Prevalence of age-related macular degeneration among elderly patients attending Alexandria Main University Hospital
by: Alaa M Fadel, et al.
Published: (2016-01-01)

Targeting the Complement Cascade for Treatment of Dry Age-Related Macular Degeneration
by: Prem N. Patel, et al.
Published: (2022-08-01)

Changes of drusen number and central retinal thickness in age-related macular degeneration patients over two years
by: Krešimir Mandić, et al.
Published: (2016-01-01)

Two-Photon Excited Fluorescence Lifetime Imaging of Tetracycline-Labeled Retinal Calcification
by: Kavita R. Hegde, et al.
Published: (2023-07-01)

Fluorescence Lifetime Imaging of Human Sub-RPE Calcification In Vitro Following Chlortetracycline Infusion
by: Kavita R. Hegde, et al.
Published: (2023-03-01)

Targeted High-Density Microperimetry Testing of Nascent Geographic Atrophy in Age-Related Macular Degeneration
by: Zhichao Wu, BAppSc(Optom), PhD, et al.
Published: (2024-03-01)

The Role of the Complement Pathway in Clinical Progression of Geographic Atrophy
by: Rose Edmonds, MS, et al.
Published: (2023-12-01)

Methodological Appraisal of Phase 3 Clinical Trials in Geographic Atrophy
by: Marc Biarnés, et al.
Published: (2023-05-01)

Research advances of modern and traditional medicine on dry age-related macular degeneration
by: Lu Xing, et al.
Published: (2022-05-01)

Geographic Atrophy after Reabsorption of Pigment Epithelial Detachment (GARPED) study
by: Enoch T. Peng, et al.
Published: (2023-05-01)

Expert Consensus on Geographic Atrophy in the EU: A Call for Urgent Policy Action
by: Giuseppe Querques, et al.
Published: (2024-02-01)

Quantitative proteomic analysis of aqueous humor from patients with drusen and reticular pseudodrusen in age-related macular degeneration
by: Je-Hyun Baek, et al.
Published: (2018-11-01)

METformin for the MINimization of Geographic Atrophy Progression (METforMIN): A Randomized Trial
by: Liangbo Linus Shen, MD, et al.
Published: (2024-05-01)

Prevalence of Geographic Atrophy in Advanced Age-Related Macular Degeneration (AMD) in Daily Practice
by: Alaa Din Abdin, et al.
Published: (2023-07-01)

Automation of Cluster Extraction in Fundus Autofluorescence Images of Geographic Atrophy
by: Janan Arslan, et al.
Published: (2023-07-01)

Letter to the Editor Regarding “LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration”
by: Salvatore Grisanti, et al.
Published: (2024-02-01)

Quantitative Autofluorescence in Non-Neovascular Age Related Macular Degeneration
by: Shruti Chandra, et al.
Published: (2023-02-01)

The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy
by: Grace A. Borchert, et al.
Published: (2023-08-01)

Visual rehabilitation via microperimetry in patients with geographic atrophy: a pilot study
by: Juan Abel Ramírez Estudillo, et al.
Published: (2017-05-01)

The Use of Fundus Autofluorescence in Dry Age-Related Macular Degeneration
by: Nedime Şahinoğlu Keşkek, et al.
Published: (2021-06-01)

Age-related macular degeneration with choroidal neovascularization in the setting of pre-existing geographic atrophy and ranibizumab treatment. Analysis of a case series and revision paper Avaliação da resposta da injeção intravítrea de ranibizumab em pacientes com neovascularização de coróide da degeneração macular relacionada à idade com atrofia geográfica extensa pré-existente e revisão da literatura
by: Miguel Hage Amaro, et al.
Published: (2012-12-01)

Subthreshold Nano-Second Laser Treatment and Age-Related Macular Degeneration
by: Amy C. Cohn, et al.
Published: (2021-01-01)

Multimodal Evaluation of Visual Function in Geographic Atrophy versus Normal Eyes
by: Burguera-Giménez N, et al.
Published: (2020-06-01)

Living with Geographic Atrophy: An Ethnographic Study
by: Sobha Sivaprasad, et al.
Published: (2019-01-01)

Rare Dysfunctional Complement Factor I Genetic Variants and Progression to Advanced Age-Related Macular Degeneration
by: Johanna M. Seddon, MD, et al.
Published: (2023-06-01)

As in Real Estate, Location Matters: Cellular Expression of Complement Varies Between Macular and Peripheral Regions of the Retina and Supporting Tissues
by: Randy Zauhar, et al.
Published: (2022-06-01)

Retinal Vessel Density in Age-Related Macular Degeneration Patients with Geographic Atrophy
by: Suji Hong, et al.
Published: (2022-03-01)